NERVGEN PHARMA CORP. — Form D

NERVGEN PHARMA CORP. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-20. The offering totals $111K, of which $111K was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Brian Eric BayleyDirectorVANCOUVER, A1
HAROLD MARTIN PUNNETTDirectorFORT LANGLEY, A1
ERNEST SHINGYAN WONGDirectorBROOMFIELD, CO
ROBERT GERHARD PILZExecutive OfficerWEST VANCOUVER, A1
ERNEST SHINGYAN WONGExecutive OfficerBROOMFIELD, CO
William Joseph RadvakPromoterVancouver, A1
Krista McKerracherDirectorBoston, MA
Paul BrennanDirectorOxford, X0
Paul BrennanExecutive OfficerOxford, X0
Michael AbramsDirectorWilmington, DE
William AdamsExecutive OfficerPONTE VEDRA, FL
Ernest WongDirectorDallas, TX
Ernest WongExecutive OfficerDallas, TX
Harold PunnettDirectorVancouver, A1
Brian BayleyDirectorVancouver, A1
Bill RadvakDirectorVancouver, A1
Bill RadvakExecutive OfficerVancouver, A1
Randall KayeDirectorVancouver, A1
Daniel MikolExecutive OfficerVancouver, A1
Glenn IvesDirectorVancouver, A1
Amy FrankeExecutive OfficerVancouver, A1
Lloyd MackenzieExecutive OfficerVancouver, A1
Robert PilzExecutive OfficerVANCOUVER, A1
Denis BoscExecutive OfficerVancouver, A1
Harold Jeffrey PunnettDirectorVancouver, A1

Other filings by this issuer (8)

FiledFormOfferingSold
2021-12-14D$1.1M$652K
2021-08-25D/A$5.4M$2.2M
2021-08-17D$442K$264K
2021-06-02D/A$650K$285K
2020-08-25D$5.4M$2.2M
2020-06-03D$650K$285K
2019-11-22D$1.5M$1.5M
2019-03-21D$1.2M$1.2M

More